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ABSTRACT
Basophil activation has been implicated in allergy reaction and immune modulation. Signaling transduction, mediator release
and morphology change of basophils have been largely deciphered. This study examined the feasibility of using proteomic strategy
to investigate the whole cell proteomic changes in KU812 basophils following activation with phorbol myristate acetate (PMA) plus
ionophore (A23187). The two-dimensional electrophoresis (2D) coupled with matrix-assisted laser desorption/ionization-quadrupole/time-of-flight (MALDI-Q-TOF) was selected for studying comparative proteome differences; and cytokine mRNA expressions
were monitored. The differentially displayed proteins were further validated by 1D- and 2D-Western blotting for protein expressions. IL-4, IL-5, and IL-13 mRNAs in KU812 were significantly induced; a phenomenon similar to the allergy reaction. The
protein expressions of heterogeneous nuclear ribonucleoprotein K (HNRPK) and a-enolase (ENO1) were shown a good correlation
according to the results from the 2D, and 2D-Western blots. Since the majority of the identified proteins were associated with immunological, inflammatory disorders and tumor genesis, this study in defining the proteomic changes in basophilic cells that occur in
response to treatment with PMA plus A23187 can serve as biomarkers for characterization of in vitro immuno-stimulation.
Key words: basophil, proteomics, immuno-stimulants, Th2 cytokine

INTRODUCTION
Due to growing prevalence of allergic diseases
worldwide, the exact molecular mechanisms of allergy
reaction for prevention and/or treatment of allergy
diseases are becoming increasingly important. Basophils and mast cells are major effector cells in allergic
progression through their highly expressed FceRI on the
cell surface (1). These events trigger both preformed and
newly synthetic chemical mediator secretions. Among
them, IL-4, IL-5 and IL-13 are major cytokines for IgE
production, facilitating Th2 differentiation and allergic
responses (2). Basophils could rapidly secrete large
* Author for correspondence. Tel: +886-2-2788-6230;
Fax: +886-2-2788-3473; E-mail: bcchen@gate.sinica.edu.tw

amount of IL-4 and IL-13, and constitutively express
CD40L and CCR3 on the surface. Basophils have been
detected in particular organs affected by allergic reactions, such as bronchial and airway biopsies from
asthma patients, nasal lavage fluids from allergic rhinitis
patients, as well as skin biopsies from atopic and contact
dermatitis. Therefore, human basophils play a crucial
role as a high priority source of IL-4, IL-13, histamine,
and leukotriene-C 4 (LTC 4) that polarize the early type 2
immune response leading to allergy and asthma (3-6).
With the advent of proteomics and allergen sequence,
biomic study of immunological molecular mechanisms
enables more rapid advances in elucidating allergic
inflammatory pathways through proteomic methodologies coupled with bioinformatic techniques. Proteomics
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characterizes cellular proteins, its abundance, modification state, protein complexes and interactions. The global
changes in cellular protein expression can be visualized
by two-dimensional gel electrophoresis (2D) and identified by mass spectrometry analysis.
Since IL-4 and IL-13 are central in allergic inflammation and share several biological properties, it is
crucial to elucidate how human basophils synthesize and
release such cytokines upon stimulation. The phorbol
12-myristate 13-acetate (PMA) induction of human basophils and KU812 cells brings about IL-13, not IL-4 secretion(4,7). The ionomycin only initiates IL-4 not IL-13
production in KU812 cells, but it induces both IL-4 and
IL-13 secretions in human basophils (4,8). Regarding the
release of histamine and LTC 4, PMA results in histamine
slowly released at the maximum level within 1 hr, but
no LTC 4 production(9). The calcium ionophore, A23187,
induces LTC 4 generation, an event which precedes histamine release (10). Recently, combinational use of PMA and
A23187/ionomycin for human immune cells such as mast
cell, basophil, T cell, B cell and neutrophil seems to be
a representative immuno-stimulant in allergic molecular mechanism, immune cell differentiation, signaling
pathway, transcriptional factor activation, and protective
lead compound screening(11-13).
The 2D couples with tandem mass spectrometry
and validation assays were utilized to evaluate changes
in comparative proteomes of human basophilic cells
following treatment with PMA and A23187. The combination of PMA and A23187 induced IL-4, IL-5 and IL-13
expressions in human basophilic KU812 cells. The significantly regulated proteins are further classified based on
metabolism, macromolecule binding, catalytic activity,
association with inflammatory immunological diseases,
tumorgenesis, and cell movement. Meanwhile, the
selected regulatory proteins as HNRPK and ENO1 were
verified by 1D- and 2D-Western blotting. This study is
the first of its kind to combine the use of immuno-stimulating treatment with proteomic platform and bioactivity
validation assays to elucidate KU812 basophil activation
induced by PMA plus A23187.

MATERIALS AND METHODS
I. Cell Culture
Human basophilic leukemia KU812 cells were
seeded at an initial concentration of 5 × 105 cells/mL in
RPMI 1640 supplemented with 10% fetal bovine serum
and maintained at 37°C in an incubator with controlled
humidified atmosphere containing 5% CO2.
II. RT-PCR Analysis of Cytokine mRNA Expressions
The KU812 cells (5 × 105 cells/mL) were treated
by PMA (10 ng/mL) plus A23187 (1 μmol/L) or an

equivalent amount of diluted dimethyl sulfoxide
(DMSO) and incubated for 3 hours. After washing,
total RNA was extracted, mixed with the reverse transcriptase (RT) mixture according to the manufacturer’s protocol (Invitrogen, Carlsbad, CA, USA) and
incubated at 42°C for 50 minutes, followed by 95°C
for 5 minutes. After each RT, PCR amplification was
performed with the following primers. IL-4–sense,
5′ ATG-GGT-CTCACC-TCC-CAA-CTG-CT 3′; antisense, 5′ GTT-TTC-CAA-CGT-ACT-CTG-GTT-GGC
3′. IL-5–sense, 5′ GCT-TCT-GCA- TTT-GAG-TTTGCT-AGC-T 3′; antisense, 5′ TGG-CCG-TCA-ATGTAT-TTC-TTT-ATT-AAG 3′. IL-6–sense, 5′ ATGAAC-TCC-TTC-TCC-ACA-AGC-GC 3′; antisense, 5′
GAA-GAG- CCC-TCA-GGC-TGG-ACT-G 3′. IL-8–
sense, 5′ ATG-ACT-TCC-AAG-CTG-GCC-GTG-GCT
3′; antisense, 5′ TCT-CAG-CCC-TCT-TCA-AAAACT-TCT-C 3′. IL-13–sense, 5′ CCA-CGG- TCATTG-CTC-TCA-CTT-GCC 3′; antisense, 5′ CCT-TGTGCG-GGC-AGA-ATC-CGC-TCA 3′. IL-1β–sense, 5′
ATG-GCA-GAA-GTA-CCT-AAG-CTC-GC 3′; antisense, 5′
ACA-CAA- ATT-GCA-TGG-TGA-AGT-CAG-TT 3′.
IFN-γ–sense, 5′ TGT-TAC-TGC-CAG-GAC-CCA- TATGTA-AAA 3′; antisense, 5′ CAT-CAC-TTG-GAT-GAGTTC-ATG-TAT-TGC 3′. β-Actin–specific primers were as
follows: sense, 5′ GTG-GGG-CGC-CCC-AGG-CAC-CA
3′; antisense, 5′ GTC-CTT-AAT-GTC-ACG-CAC-GATTTC 3′. The PCR process was performed with a Thermo
Px2Thermal Cycler (San Jose, CA, USA). The products
were electrophoresed in 2% agarose gel, stained with
ethidium bromide, photographed, and quantitated by
computer program.
III. Two Dimensional (2D) Electrophoresis
KU812 cells were resuspended in lysis buffer at 350
µL, as described previously(14). The protein solutions
(150 µg protein) were applied onto IPG strips (18 cm, pH
3-10NL)(GE Healthcare Life Sciences, Pittsburgh, PA,
USA). After rehydration, isoelectric focusing (IEF) was
conducted at 8000 V for 66000 Vh. The equilibrated
strips were then transferred onto 12.5% homogenous polyacrylamide slab gel (18 × 18 cm), and separated proteins
were then visualized with SYPRO® Ruby dye (Bio-Rad,
Hercules, CA, USA). The 2D gel images were scanned
using a Typhoon 9200 laser scanner (GE Healthcare
Life Sciences, Pittsburgh, PA, USA) and exported to the
image analysis software program using PDQuest software
package version 7.1.1 (Bio-Rad, Hercules, CA, USA).
IV. In-gel Digestion
The in-gel digestion procedure was processed
according to our previous study(14). Briefly, the gel pieces
were washed and rehydrated with trypsin (Promega,
Madison, WI, USA) at 37°C for at least 16h. The
extracted peptides were finally eluted with 5 µL of 75%
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acetonitrile/0.1% formic acid, and directly spotted on the
sample plate of a MALDI-Q-TOF mass spectrometry.
V. MALDI-TOF and MALDI-Q-TOF Mass Spectrometry.
The trypsinized samples were premixed in a ratio of
1:1 (v/v) with the matrix solution (5 mg/mL α-cyano-4hydroxycinnamic acid (CHCA) in 50% acetonitrile, 0.1%
v/v trifluoroacetic acid and 2% w/v ammonium citrate)
and spotted onto the 96-well MALDI sample stage. The
samples were analyzed by the Q-TOF Ultima™ MALDI
instrument (MALDI™; Micromass, Manchester, UK),
as described previously(9). The MASCOT search engine
(http://www.matrixscience.com) was used for MS/MS
ions search using a MALDI-Q-TOF-MS hybrid quadrupole/orthogonal acceleration TOF spectrometer
(MALDI TM, Micromass, Manchester, UK). The product
ion spectra generated by Q-TOF MS/MS were searched
against NCBInr and Swiss-PROT databases for exact
matches using the Mascot search program.
VI. 1D- and 2D-Western Blotting Verification of HNRPK
and ENO1 Protein Level Expressions
After 1D and 2D procedures, proteins were transferred onto PVDF membranes (GE Healthcare Life
Sciences, Pittsburgh, PA, USA). Primary antibodies
including HNRPK and ENO1 were purchased from
Abcam (Abcam, Cambridge, UK). After incubation with
secondary antibodies, the immunoblots were visualized
with the ECL detection kit (GE Healthcare Life Sciences,
Pittsburgh, PA, USA) then exposed to X-ray film, or
Luminescent Image Analyzer LAS-4000 (Fujifilm,
Tokyo, Japan).
VII. Statistical Analysis
Analysis of proteins regulation changed upon PMA
plus A23187 treatment was done on three independent
experiments. Each set of 2D gels was compared separately by an image comparison software. Different
proteins that were found in all sets of experiment were
selected for identification.
VIII. Bioinformatics Tools for Protein Searches
The protein search programs used the following
sequential order of databases: NCBI (http://www.ncbi.
nlm.nih.gov), Swiss-Prot/TrEMBL (http://www.expasy.
ch/sprot) and Proteome (http://www.proteom.com/databases/HumanPD/reports). In addition, the functional
protein association networks or protein interactions were
searched by STRING database (http://string.embl.de/).
The combining pathway databases of BioCarta (http://
www.biocarta.com), KEGG (http://www.genome.ad.jp/
kegg/pathways.html) and the PubMed literature (http://
www.ncbi.nlm.nih.gov/PubMed) were also used to search

the correlated regulatory pathways of cellular response
in KU812 and other immune cells. The two bioinformatic
tools including our previous work as Bulk Gene Search
System for Java (BGSSJ)(15). The Ingenuity Pathway
Analysis (IPA) was applied in thoroughly compiling
protein functional classification and interaction networks.

RESULTS
I. Cytokine Expressions of KU812 after PMA plus A23187
Treatment
We treated human basophil cells KU812 with PMA
(10 ng/mL) and A23187 (1 μmol/L). The PMA structure was analogous to diacylglycerol that activates
protein kinase C. The A23187 was a calcimycin that
greatly increases the ability of Ca 2+ crossing biological
membranes. In RT-PCR, mRNA expressions of the cytokine genes were normalized to each sample by using
β-actin gene as internal controls. The up-regulation of
IL-4, IL-5, IL-6, IL-8, IL-13, and IFN-γ (no IL-1β), was
detected after PMA plus A23187 stimulation at 3 hours.
The typical Th2 cytokines consisting of IL-4, IL-5
and IL-13 were apparently enhanced more than 2 fold
changes (Figure 1). The IL-5 elevated to the highest level
at 5 fold changes among all test cytokines. The combination treatment with PMA and A23187 stimulated KU812
cells elevation of Th2 type cytokine mRNA expression
levels.
II. Expression Changes of 17 Identified Proteins in KU812
after PMA plus A23187 Treatment
The time-course experiments were conducted
at least three times and showed good reproducibility
among different cell batches and 2D gels (Supplementary Figure 1). The 2D patterns revealed that the largest
number of significantly-regulated proteins occurred at
6h treatments using the PDQuest analysis. We identified

IL-4

IL-5

IL-6

IL-8

IL-13

IL-1b

IFN-g

b-actin

Figure 1. RT-PCR patterns for cytokines of human basophil cell line
KU812.
Blank (left): no treatment; Control (middle): treated only with an
equivalent amount of diluted DMSO; Treated (right): stimulated
with PMA plus A23187 for 3h.
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Table 1. Summary of significantly regulated proteins in total cellular lysates of KU812 cells in a time course treatment study with PMA plus
A23187 using the MALDI-Q-TOF analysis
Spot

Change

Accession

Con 3h 6h 12h

Sprota

Protein name

Score

Theoretic
Mr (kD)

pI

SCb

Matched sequences

Up-regulated
1

P61978

Heterogeneous nuclear
ribonucleoprotein K
(HNRPK)

37

50.9

5.39

2

NLPLPPPPPPR

2

P60842

Eukaryotic initiation
factor 4A-1 (EIF4A1)

126

46.1

5.32

8

GIYAYGFEKPSAIQQR
AEVQKLQMEAPHIIVGTPGR

3

Q01105

Protein SET (SET)

55

33.5

4.23

8

LRQPFFQK
SGYRIDFYFDENPYFENK

4

P46783

40S ribosomal protein
SA (RPSA)

85

32.8

4.79

11

AIVAIENPADVSVISSR
FTPGTFTNQIQAAFREPR

5

P07437

Tubulin β-5 chain
(TUBB)

211

49.6

4.78

10

ISVYYNEATGGKYVPR
LHFFMPGFAPLTSR
MAVTFIGNSTAIQELFKR

6

P10809

Heat shock protein 60
(HSPD1)

214

61.0

5.70

6

TLNDELEIIEGMKFDR
KISSIQSIVPALEIANAHR
ISSIQSIVPALEIANAHR

7

P60709

Actin β-chain (ACTB)

275

41.7

5.29

23

AVFPSIVGRPR
VAPEEHPVLLTEAPLNPK
LCYVALDFEQEMATAASSSSLEK
SYELPDGQVITIGNER
DLYANTVLSGGTTMYPGIADR

8

P62736

Actin α-chain (ACTA)

57

42.0

5.23

4

SYELPDGQVITIGNER

Down-regulated
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Table 1. Continued.
Spot

Change

Accession

Con 3h 6h 12h

Sprota

Protein name

Score

Theoretic
Mr (kD)

pI

SCb

Matched sequences

9

P23381

Tryptophanyl-tRNA
synthetase, cytoplasmic (WARS)

126

53.1

5.83

7

ISFPAIQAAPSFSNSFPQIFR
ALIEVLQPLIAEHQAR

10

P06733

a-enolase (ENO1)

70

47.1

7.01

3

LAMQEFMILPVGAANFR

11

P54577

Tyrosyl-tRNA synthetase, cytoplasmic
(YARS)

51

59.1

6.61

3

TVVSGLVQFVPKEELQDR

12

P06733

α-enolase (ENO1)

258

47.1

7.01

12

EIFDSRGNPTVEVDLFTSK
LAMQEFMILPVGAANFR
AGYTDKVVIGMDVAASEFFR

13

P06733

α-enolase (ENO1)

67

47.1

7.01

8

LAMQEFMILPVGAANFR
AGYTDKVVIGMDVAASEFFR

14

Q6FH94

Fructose-bisphosphate
aldolase C (ALDOC)

75

39.4

6.41

4

TPSALAILENANVLAR

15

P07954

Furmarate hydratase
(FH)

33

54.6

8.85

4

THTQDAVPLTLGQEFSGYVQQVK

16

P62333

26S protease regulatory subunit (PSMC6)

63

44.1

7.10

3

EVIELPLTNPELFQR

17

P04075

Fructose-bisphosphate
aldolase A (ALDOA)

51

39.4

8.30

5

IGEHTPSALAIMENANVLAR
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Table 1. Continued.
Spot

a

Change

Accession

Con 3h 6h 12h

Sprota

Protein name

Theoretic

Score

Mr (kD)

pI

SCb

Matched sequences

18

P04406

Glyceraldehyde-3phosphate dehydrogenase (GAPDH)

128

36.0

8.57

11

VIHDNFGIVEGLMTTVHAITATQK
LISWYDNEFGYSNR

19

P07737

Profilin-1 (PFN1)

126

15.0

8.44

12

TFVNITPAEVGVLVGK
TFVNITPAEVGVLVGKDR

Accession number from UniProtKB/Swiss-Prot.
SC stands for Sequence Coverage from Mascot search result.

b

(A) Up-regulated proteins
pI

3

(B) Down-regulated proteins
10

pI

97-

97-

66-

66-

45-

45-

30-

30-

20-

20-

14-

14-

3

10

Figure 2. The representative 2DE gel for 6 hr PMA plus A23187 treatment.
Protein spots present in the pI range of 3-10 and molecular weight range of 14-97 kD. (A) The up-regulated proteins are shown in the gel
of 6h treatment group. (B) The down-regulated proteins are shown in the gel of control group. The 2D experiments for each group were
conducted at least three times with good reproducibility among different cell batches and 2D gels (Supplementary Figure 1). Statistically
significant variations were defined as a minimum 2 fold changes in expression level and P<0.05 at 6 h compared to protein expression level
in control group.

2 up-regulated proteins (heterogenous nuclear ribonucleoprotein K (HNRPK) and eukaryotic initiation factor
4A-1 (EIF4A1), and 15 down-regulated protein expressions including protein set (SET), 40S ribosomal protein
SA (RPSA), tubulin β-5 chain (TUBB), heat shock
protein 60 (HSPD1), actin β-chain (ACTB), actin α-chain

(ACTA), tryptophanyl-tRNA synthetase, cytoplasmic
(WARS), α-enolase (ENO1), tyrosyl-tRNA synthetase,
cytoplasmic (YARS), fructose-bisphosphate aldolase C
(ALDOC), furmarate hydratase (FH), 26S protease regulatory subunit (PSMC6), fructose-bisphosphate aldolase
A (ALDOA), glyceraldehyde-3-phosphate dehydrogenase
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(GAPDH) and profilin-1 (PFN1) at 6h treatment (Table
1). Statistically significant variations were defined as a
minimum 2-fold changes and p < 0.05 when comparing
to protein expression levels among control and treatment
groups.
The 2 up-regulated protein spots were shown in a
representative 6h-treatment gel, and 15 down-regulated
protein spots were revealed in control group (Figure
2). The computerized close-up vision for each spot was
collected (Figure 3), and optical density of identified
spots from three independent experiments were analyzed
and piled up into histograms (Table 1). To identify
protein spot individually, the 3D diagram utility provided
by PDQuest was subjected to careful examination of each
spot. The HNRPK and EIF4A1 levels had 2-fold elevation with time increases at 6h. In contrast, the SET,
RPSA, ALDOA levels were markedly reduced by 4-fold

Con

3h

6h

12h

at 6h time point but gradually increased at 12h. The
remaining down-regulated proteins reached a peak at 3h
and declined at 6h down to 30-50% levels comparable to
untreated cells at 3h. Furthermore, we identified specific
isoforms and several spots for one protein identity for
HNRPK (up-regulated) and ENO1 (down-regulated). The
five protein spots of HNRPK revealed 3 up-regulated and
2 down-regulated isoforms (data not shown); however,
only one up-regulated spot was shown due to statistical significance. On the other hand, the three ENO1
spots showed significant reductions at 6h compared to
control group. These spots with varied mobility indicated
possible alternative splicing, post-transcriptional or posttranslational modifications for ENO1 and HNRPK.
III. Verification of Significantly-Regulated Proteins by 1D& 2D-Western Blotting
From the time-course 1D-Western blotting analyses
(Figure 4A), the 6h treated cells seemed to have a slightly
higher HNRPK expression than the untreated KU812
cells. In contrast, ENO1 exhibited a slightly elevated
level in the untreated KU812 cells. We further conducted
2D-Western blotting analysis to better understand the
expressions of isoforms for HNRPK and ENO1 (Figure
4B). The acidic isoform (indicated by a) of HNRPK in 6h
PMA plus A23187-stimulated KU812 cells was significantly higher than that in the untreated KU812 cells.
This spot might result from inducible phosphorylation of HNRPK by PMA plus A23187 treatment. Other
HNRPK isoforms did not show significant variances. On

(A)

(B)

Figure 3. Close-up view of PMA plus A23187-dependent expression
of 17 identified proteins. Gel sections (1-19) represent varied expression of the indicated protein spots at different time periods.

Figure 4. HNRPK and ENO1 validations were achieved by 1D- and
2D-Western blotting. (A) 1D-Western blotting of KU812 cells at
differential time points. (B) 2D-Western blotting of KU812 cells at 6
h PMA plus A23187 treatment.
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the contrary, almost all ENO1 isoforms (indicated by a to
e) exhibited down-regulation after 6h PMA plus A23187
treatment. These 2D and 2D-Western blotting results
showed a good correlation.

(A) Cellular component
10%
24%

Cytoplasm
Nucleus
Plasma Membrane

IV. Subcellular and Functional Classification
We used 2 bioinformatic tools including our
previous work as Bulk Gene Search System for Java
(BGSSJ) shown in Figure 6, and Ingenuity Pathway
Analysis (IPA) shown in Table 2 to thoroughly compile
protein functional classification and interrelationships.
The PMA plus A23187-stimulated proteins correlate
primarily to immunological disorder (ACTA, ACTB,
ALDOA, ENO1, GAPDH, RPSA, TUBB), and tumorgenesis (ACTB, ALDOA, ALDOC, ENO1, FH, PFN1,
TUBB) (Table 2). From subcellular localization analysis,
the identified proteins were mainly distributed in the
cytoplasm, followed by nucleus and plasma membrane
(Figure 5A). The proteins in the nucleus consist of
HNRPK, SET, RPSA, PSMC6, and PFN1 according
to BGSSJ and IPA databanks. Primary metabolism on
carbohydrate, protein, and nucleic acid plays an important role in the physiological process (Figure 5B). From
molecular function classification, the identified proteins
abundantly bind to protein, nucleotides, nucleic acid, and
metal ion (Figure 6C).

DISCUSSION
Basophils comprise less than 1% of peripheral blood
leukocytes and serve as primary Th2 type effector cells
during allergic inflammation and parasite infection(5,16).
Activated basophils produce rapid cytokine release due
to sufficiently preformed IL-4 and IL-13 mRNA transcripts in basophil ontology (17). In addition to IL-4 and
IL-13, IL-5 and IFN-γ were greatly elevated in PMA plus
A23187-stimulated KU812 cells within 3h in this study
(Figure 1). The phenomenon is similar in chronic urticaria patients that PMA plus ionomycin heavily enhanced
both IL-4 and IFN-γ productions in CD4+ lymphocyte (18). Human basophils are a more effective source
of IL-4 than mast cells or eosinophils. Human basophils
release equivalent IL-4 amount as FcεRI-activated Th2
cells. The activated basophils provided early IL-4 source
which might drive naïve CD4 T cells to IL-4-producing
Th2 phenotypes in vitro and in vivo (19,20). Even IL-4
deficient basophils still could inhibit naïve CD4 T cells
differentiate into Th1 cells, although they did not help in
Th2 differentiation(21). Basophils might serve as a potential connection between innate and adaptive immunity.
Basophils serve as an initiator and a good therapeutic
target in IgE-mediated chronic allergic inflammation
from basophil-depleting mAb studies (22).
PMA plus A23187 induces histamine (12), IL-4, IL-5,
IL-6, IL-8 and IL-13 protein secretions in activated

66%

(B) Biological process
7%

7%

3%

10%
53%
10%
10%

Metabolism
Death
Localization
Regulation of physiological process
Organismal physiological process
Unknown
Physiological response to stimulus

(C) Molecular function
7% 4% 4%
7%

45%

Binding
Catalytic activity
Signal transducer activity
Structural molecule activity
Translation regulator activity
Motor activity

33%

Figure 5. Functional classification assay conducted by the Bulk Gene
Search System for Java (BGSSJ). (A) Localization, (B) Biological
process, and (C) Molecular function.

basophil cells(11). They also enhance CD40 ligand(13),
and phosphorylation of cytoplasmic p38 MAPK, p44/42
MAPK, p54/46 SAPK/JNK, as well as nuclear c-Jun
phosphorylation both on ser63 and ser73(23). PMA and
A23187 increased DNA-binding activity of phosphorylated c-Jun, JunB, JunD, c-Fos, and FosB nuclear extracts
of KU812 cells (23).
Heterogeneous nuclear ribonucleoproteins (hnRNP)
are predominantly nuclear RNA-binding proteins that
involve in a range of RNA life including splicing,
processing, export of the mature RNAs and translation, and signal transduction that influence gene expression (24). The hnRNP family was recently regarded as an
important target of the autoimmune response in rheumatic diseases. The hnRNP-K (HNRPK) was associated
to rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and mixed connective tissue disease (25). The
HNRPK was significantly up-regulated by 6h PMA plus
A23187 stimulated KU812 cells. From 2D-western blot
of HNRPK, a spot (indicated by a) appeared at the more
acidic side. HNRPK were phosphorylated at multiple
sites, especially on tyrosine residues, in response to
various signals. HNRPK was assumed to be a target of
SH2-containing protein tyrosine kinases such as Src,
Lck, Lyn and Fyn(24). B cell receptor (BCR) activation
did not change HNRPK concentration in 1D immunoprecipitated protein, but greatly enhanced 1D and 2D
immunoblotting with anti-phosphotyrosine antibodies,
which cause inducible phosphorylation of HNRPK(26).
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Table 2. Functional classification of significantly regulated proteins by Ingenuity Pathway Analysis (IPA) Software
Function

Protein symbol

Immunological Disease
Acute allergic pulmonary eosinophilia

ACTBa, ALDOA, ENO1, GAPDH, TUBB

Immunological disorder

ACTA, ACTB, ALDOA, ENO1, GAPDH, RPSA, TUBB

Rheumatoid arthritis and autoimmune disease

ACTA, ALDOA, ENO1, RPSA

Cancer
Tumorgenesis and neoplasia

ACTB, ALDOA, ALDOC, ENO1, FH, PFN1, TUBB

Carcinoma, primary and malignant tumor

ALDOA, ALDOC, ENO1, PFN1, TUBB

Lung cancer, lung tumor, lung adenocarcinoma, lung carcinoma

ALDOA, ALDOC, ENO1

Growth and development of breast cancer cell lines

HNRPK, PFN1

Attachment and invasion of melanoma cell lines

RPSA

Migration of fibrosarcoma cell lines

HNRPK

A poptosis of tumor cells

GAPDH, ENO1

Cellular assembly and organization
Formation of filaments

ACTA, PFN1, TUBB

Formation of microspikes and actin

PFN1

Formation of mitotic spindle and spindle fibers

TUBB

Formation of myofilaments

ACTA

Formation of nucleosomes

SET

Binding of microsomal membrane

GAPDH

Binding of ribosome

EIF4A1

Inflammatory disease
Inflammatory disorder

ACTA, ALDOA, ENO1, GAPDH, HSPD1, RPSA

Rheumatic arthritis disease

ACTA, ALDOA, ENO1, RPSA

Iridocyclitis, and uveitis

HSPD1

Acute respiratory distress syndrome

GAPDH

Cellular growth and proliferation
Growth of cells

ACTB, EIF4A1, ENO1, HNRPK, HSPD1, PFN1, RPSA, SET

Growth of breast cancer cell lines

HNRPK, PFN1

Cellular movement
Cell movement

ACTB, HNRPK, HSPD1, TUBB, WARS, YARS

Cell movement of fibrosarcoma cell lines

HNRPK

 hemotaxis and homing of mononuclear leukocytes, blood cells and
C
lymphatic system cells

HSPD1, YARS

Migration of eukaryotic cells

HNRPK, HSPD1, WARS, YARS

Invasion of melanoma cell lines

RPSA
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Table 2. Continued.
Function

Protein symbol

Carbohydrate metabolism
Glycolysis

ALDOA, ENO1

Metabolism of fumaric acid

FH

Quantity of UDP-N-acetylglucosamine

GAPDH

Binding of lipopolysaccharide

RPSA

Small molecular biochemistry
Aminoacylation

WARS, YARS

Recovery of ATP

HSPD1

Production of niric oxide

HSPD1, PFN1

Gene expression

a

Activation of synthetic promoter

ACTB, GAPDH, HNRPK, SET

Recruitment and binding of mRNA

EIF4A1

Transactivation of protein binding site

ENO1

Transactivation of synthetic promoter

GAPDH, HNRPK

Refer to Table 1 for protein abbreviations.

Our immunoblotting results agreed with the phenomena
of BCR activation, indicating that PMA plus A23187
might induce phosphorylation of HNRPK in KU812
cells (Figure 4B). Regarding cancer biology, HNRPK
increased transcriptional activation of the c-myc gene
and oncogene c-Src related to cancer development,
survival, and migration. The HNRPK was identified as
the potential targeted protein of cancer metastasis from
loss-of-function screening by randomized intracellular
antibodies. Furthermore, the cytoplasmic accumulation
of HNRPK played an important role in metastasis (27)
and colorectal cancer (28). The HNRPK protein elevated
at 6h PMA plus A23187 treatment might enhance DNA
and RNA binding activity, transcriptional and translational modulating activity. The PTM study of HNRPK on
KU812 cells upon treatment with PMA and A231Enolase
is a multifunctional protein abundantly expressed in the
cytoplasm and serves as Myc-binding protein (MBP-1)
in the nucleus. Enolase is a plasminogen receptor on
the surface of the hematopoetic, epithelial and endothelial cells. Auto-antibodies to airway epithelial cells
(A549) were examined in sera from patients with severe
asthma (29). Anti-enolase antibodies have been incriminated in various inflammatory and autoimmune diseases
including SLE, RA, mixed cryoglobulnemia (MC),
systemic sclerosis (SSc), Behcet’s disease, multiple
sclerosis, Hashimoto’s encephalopathy (HE), and paraneoplastic retinopathy (30). Anti-enolase antibodies

could serve as prognostic indicators for autoimmune or
neoplastic disorders but not diagnostic biomarkers due to
broad distribution in numerous diseases. ENO1 was also
a highly conserved fungal allergen and its IgE-binding
epitopes were elucidated. PMA treated hematopoietic
cells such as B cells, T cells, monocytes, neutrophils
showed greater amounts of ENO1 on their surface. The
translocation of ENO1 seemed to be associated with its
hydrophobic domain,
posttranslational acylation or
phosphorylation. The isoform of ENO1 detected by our
2D-western blot at 6h PMA plus A23187 treatment were
significantly decreased (Figure 4B). Such drastic change
of ENO1 expressions in the treated-KU812 cells with
PMA plus A23187 might be associated with the ENO1
location or its posttranslational modifications. This area
needs to be further investigated.
The tubulin beta-5 chain (TUBB) is a major constitute of microtubules responsible for cell mobility. It
belongs to MHC I binding protein and is associated to
NK-mediated cytotoxicity. The TUBB was identified
as autoantigen in allergic rhinitis, and 52% of allergic
rhinitis patients possessed anti-TUBB autoantibodies (31).
Pharmacological and morphological data revealed that
the cytoskeleton as tubulins and actin associated to
histamine secretion in basophil and mast cells. Furthermore, IL-3 and anti-IgE alone did not promote tubulins
synthesis, but combinational treatment can induce both
histamine release and tubulins up-regulation(32).
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The 60 kDa heat shock protein (HSPD1) resulted in
mitochondrial protein transportation and macromolecule
assembly. The HSPD1 were proven to possess dominant immuno-modulatory capability in innate, adaptive immune systems, autoimmune, and tumor immunology(33). Although the dichotomous immunoregulatory
ability is still not completely elucidated, the intracellular (self) HSPD1 is generally regarded as chaperonin
and anti-inflammatory. On the other hand, extracellular
(from pathogenic organisms) HSPD1 is associated to proinflammatory(34). Due to admirable immunogenicity of
HSP family, HSP have been designed for their adjunct
use in vaccines (34). HSPD1 down-regulation in KU812
cells upon PMA and A23187 stimulation (Table 1) might
point toward immunological inflammatory pathway.
The actin family was mainly involved in cell
motility and ubiquitously expressed in eukaryotic cells.
In rat basophilic leukemia (RBL-2H3), both F-actin and
myosin were remolded into membrane ruffles and aggregations, and followed by parallel stress fibers located on
the ventral membrane originally from plasma membrane
during secretion of histamine after PMA or A23187
treatment (35).
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
ENO1 and ALDOA are key enzymes in glycolysis.
Fumarate hydratase (FH), a major enzyme in citric acid
cycle, function as interconversion of malate and fumarate. PMA plus A23187 synergistically activate H 2O2
generation in cultured porcine thyroid cells through activating protein kinase C and increasing cytoplasmic free
calcium, respectively(36). Oxidizing agents as H 2O2 were
shown to carbonylate and induce polypeptide degradation in glycolytic enzymes including ENO1, pyruvate
kinase, and GAPDH(37). ENO1 was a primary target of
H 2O2- or O2- -mediated carbonylation in Escherichia coli
(38)
. Posttranslational modification of glycolytic enzymes
was recognized as an intracellular sensor of oxidative
stress (39). We detected down-regulation of glycolytic
enzymes including ALDOA, ALDOC, FH, ENO1 and
GAPDH in PMA plus A23187 treated KU812 basophils.
Therefore, the carbohydrate catabolism was reduced
possibly through the production of oxidizing agents
induced by the PMA plus A23187 treatment.
The inconsistency between 1D- and 2D-Western
blots might be caused by the following reasons: (1) the
alternative splicing transcript variants of HNRPK and
ENO1 could not be recognized by 1D-western blots; (2)
phosphorylated HNRPK was not revealed by 1D-Western
blots, but the more acidic isoform of HNRPK up-regulated in the PMA plus A23187 treated KU812 cells
(shown in the 2D-Western blots). This finding agreed
with the inducible phosphorylation of HNRPK in the
BCR activation(26), and in response to the oxidative
stress that was possibly induced by PMA plus A23187
treatment (36); (3) the isoforms of ENO1 largely shifted in
the pI and Mw range of the 2D gel(40) so that the selected
2D region for Western blots could include the major (not

all) isoforms of ENO1.
In summary, numerous differentially expressed
proteins were identified in PMA plus A23187-activated
KU812 cells. Most of these proteins were the key factors
involved in metabolism, macromolecule binding, and
catalytic activity, and were associated with inflammatory immunological diseases, tumorgenesis, and cell
movement. HNRPK and ENO1 variations were consistently validated by protein level exanimations. However,
further functional study of these proteins may lead to
better understanding of the activation mechanisms for
PMA plus A23187 treatment.
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